SAS | The Power to Know
White Paper

Argyle Conversations: Marketing analytics helps Pfizer deliver healthy value propositions

The importance of creating and articulating a value proposition that serves both businesses and consumers

About this paper

It used to be that having a good product or a new mechanism in the pharmaceutical industry gave you a reasonable amount of market success. Today, things are very different. This Argyle Conversations paper features an interview between Robert Besthof, Vice President of Commercial Development, Neuroscience and Pain, at Pfizer, and Christian Nimsch, Head of the Center for Health Analytics and Insights at SAS, about the evolving role of marketing in the pharmaceutical industry and how critical a role marketing analytics plays today in creating and articulating a value proposition that serves both businesses and consumers. Read this paper to learn more about the steps Pfizer takes to successfully develop value propositions for its products.

About SAS

SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.

Have a SAS profile? To complete this form automatically Sign In

  Yes, I would like to receive occasional emails from SAS Institute Inc. and its affiliates about SAS products and services. I understand that I can withdraw my consent at any time by clicking the opt-out link in the emails.

All personal information will be handled in accordance with the SAS Privacy Statement.


Back to Top